Cleveland Primecare - Dr. Miodrag Zivic
25200 Chagrin Boulevard, Suite 300, Beachwood
4.6(30 Google reviews)
United States
2 listed treatment centers serving Cleveland Heights and the surrounding area.
25200 Chagrin Boulevard, Suite 300, Beachwood
4.6(30 Google reviews)
Every dose is given in a certified healthcare setting, followed by at least two hours of monitoring. Arrange transportation home after each visit. Distances below are straight-line miles from Cleveland Heights.
3.8 miles away · Shaker Heights
4.7 miles away · Beachwood
25101 Chagrin Boulevard, Suite 100, Beachwood
4.7 miles away · Beachwood
25101 Chagrin Boulevard, Suites 100 & 200, Beachwood
4.9(22 Google reviews)
9.8 miles away · Independence
6500 Rockside Road, Suite 385, Independence
4.9(39 Google reviews)
9.9 miles away · Independence
For people in Cleveland Heights, the cost of SPRAVATO® depends on insurance benefits, the treatment setting, and the prescribed visit schedule. Ask for an estimate that separates the medication from the supervised treatment and monitoring visit: both may be billed. Your share may depend on deductibles, copays, coinsurance, and whether the center is in network.
Prior authorization is common. Your insurer may request records of earlier antidepressant trials before deciding whether to approve treatment. Ask the center which records it needs, such as medication names, doses, treatment dates, and how you responded. If those records are held by another prescriber, arranging their transfer early may help avoid administrative delays. Authorization is not a guarantee that every charge will be paid.
Medicare coverage may fall under Part B or Part D, depending on the plan and setting. Ohio Medicaid coverage also depends on the plan and applicable requirements. Do not assume that a listed center accepts either program; confirm with the center and your insurer.
Manufacturer savings programs exist for eligible commercially insured patients, but not for patients using government insurance. Ask about current eligibility rules and which charges a program may help with; medication assistance may not address every visit-related expense.
Before starting, ask:
SPRAVATO® treatment requires repeat visits to a healthcare setting certified through the SPRAVATO® REMS program. You give yourself the nasal spray under direct observation of a healthcare provider; it is never sent home for use. A directory listing does not by itself confirm current certification, so verify that with the center before scheduling.
For treatment-resistant depression, the typical labeled schedule starts with twice-weekly visits during weeks 1–4, followed by weekly visits during weeks 5–8. Maintenance may be weekly or every two weeks, as individualized by your prescriber. Ask which schedule applies to your situation rather than assuming visits will decrease on a fixed timetable.
Plan for at least two hours of monitoring after each dose, plus time for check-in, preparation, and discharge assessment. The full appointment may take longer. Discuss recurring appointment blocks or time off with your employer, and leave room for changes to the treatment plan.
You need someone else to drive you home. You must not drive or operate machinery until the next day after a restful sleep. Arrange a reliable ride for every session and a backup if your usual driver becomes unavailable. Ask the center about its discharge and pickup requirements before relying on a taxi or rideshare.
If no Cleveland Heights center is listed when you search—or local options cannot accommodate you—check listings in Beachwood or Cleveland. Akron and Strongsville are other cities with listed centers. Confirm certification, appointment availability, and insurance participation directly, then consider whether the repeated travel and ride arrangements are workable.
Start with the Cleveland Heights directory listings, then contact the centers directly. The supplied listings do not establish current REMS certification. Ask whether the location is currently certified to provide Spravato, is accepting new patients, and can evaluate your needs. If local appointments are unavailable, you can also check listings in Beachwood or Cleveland without assuming those locations have openings or accept your insurance.
Spravato is FDA-approved for adults with treatment-resistant depression, either alone or with an oral antidepressant. It is also approved for depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior, together with an oral antidepressant. It is not approved for children. A prescriber must review your history and health to decide whether it is appropriate; a diagnosis alone does not guarantee eligibility.
Coverage depends on your plan, the treatment setting, and the center’s insurance participation. Prior authorization and documentation of earlier antidepressant trials are common requirements. Ask your insurer about both the medication and the supervised monitoring visit, since both may be billed. Medicare and Ohio Medicaid may cover treatment depending on the plan and setting, but do not assume a listed center accepts either program.
You self-administer the nasal spray under direct observation at a REMS-certified healthcare setting. After each dose, staff monitor you for at least two hours for effects including sedation, dissociation, breathing problems, and blood pressure increases. Allow additional time for preparation and discharge assessment. Arrange someone else to drive you home, and do not drive or operate machinery until the next day after a restful sleep.
Discuss sedation, dissociation—feeling disconnected from yourself or your surroundings—respiratory depression, and blood pressure increases. Spravato carries boxed warnings for sedation, dissociation, respiratory depression, abuse and misuse, and suicidal thoughts and behaviors. It is a Schedule III controlled substance. Share your medical history and medications with the prescriber, and ask how staff monitor these risks and determine when you can leave.
No. Spravato has not been shown to prevent suicide or reduce suicidal thoughts or behavior, and it does not replace hospitalization when clinically needed. Its approval for depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior requires use with an oral antidepressant. If you are in crisis, call or text 988. If there is immediate danger or a medical emergency, call 911 rather than waiting for a treatment appointment.
Approved uses, nearby treatment centers, and medically sourced patient guides.